baber/WOPTO huggingface dataset:
Patent AT-E142724-T1 (AT)
Inventor: HORAND DIETER
IPC: D21H11/14
Filed: 1994-01-28
Granted: 1996-09-15
Abstract: PCT No. PCT/EP94/00248 Sec. 371 Date Sep. 21, 1995 Sec. 102(e) Date Sep. 21, 1995 PCT Filed Jan. 28, 1994 PCT Pub. No. WO94/19537 PCT Pub. Date Sep. 1, 1994In a web printing paper the base paper comprises of more than 50% wt. de-inked recycled fibers, 10-35% wt. mineral filler and the remainder being wood-pulp and/or cellulose and has a weight of 30 to less than 60 g/m2. The base paper is coated with a coating having a weight of 2 to 8 g per m2 and side and the binder proportion is no more than 15% wt. in relation to the coating pigment.
Patent AT-E145935-T1 (AT)
Inventor: LAGO GITAREUX PATRICE
IPC: C11D1/29
Filed: 1994-03-07
Granted: 1996-12-15
Abstract: Described is a composition for cleaning ovens, stoves and grills, the composition containing as active ingredients on the one hand a basic primary material consisting, in particular, of an alkaline base such as sodium carbonate or potash and/or one or more amines and on the other hand a non-volatile solvent, the composition containing 10 to 30 % by wt. of a solvent mixture made up on the one hand of at least one propylene glycol ether and on the other hand of at least one dipropylene glycol ether, the ratio of propylene glycol ether to dipropylene glycol ether being between 30:70 and 90:10. The composition is suitable above all for use on self-cleaning ovens and stainless-steel ovens.
Patent AT-E194431-T1 (AT)
Inventor: CHU ALBERT E
IPC: G01N21/82
Filed: 1994-02-24
Granted: 2000-07-15
Abstract: A method and system for automatically analyzing the presence of an analyte in a liquid specimen of biological origin are described. The liquid specimen is added to a testing substrate that has a receptor immobilized on a portion of its surface. If analyte is present in the specimen, it will specifically bind to the receptor. A labeled reagent is added to the testing substrate which will bind to the analyte, if present, and generate a color on the testing substrate. The testing substrate is then illuminated and, using electronic equipment, a digital image of its surface is acquired and automatically scanned to locate an area that has the highest color density, which corresponds to the presence of labeled reagent. A measurement of color density, corresponding to pixels per unit area, is generated. An area peripheral to the area of highest color density, which represents background density, is also located and a measured. The presence or absence of analyte in the liquid sample is determined by adjusting the measurement of labeled reagent with the background density measurement in accordance with a predefined mathematical function. In some cases, the result of the test will be interpreted as a binary, positive/negative result according to whether the measurement taken is above or below a given threshold. In other cases, a continuous range of values may be generated from different samples that correspond to the concentration of the analyte present in each tested sample.
Patent AT-E141384-T1 (AT)
Inventor: BUNZL HELMUT HEINZ
IPC: E05D15/48
Filed: 1994-03-25
Granted: 1996-08-15
Abstract: PCT No. PCT/EP94/00955 Sec. 371 Date Oct. 20, 1995 Sec. 102(e) Date Oct. 20, 1995 PCT Filed Mar. 25, 1994 PCT Pub. No. WO94/23167 PCT Pub. Date Oct. 13, 1994Revolving door having at least four variable length door wings extending radially into a passageway, and being offset from one another in the direction of rotation about a central axis. Each door wing includes at least two sliding door elements slidingly movable relative to each other to vary the radial length of the door wings. Each door wing has a pivot axis disposed radially outwardly from the central axis. Adjacent door wings are pivotable about their respective pivot axes from an operating position in which the door wings extend radially into the passageway to an open position in which the sliding door elements slide relative to each other to shorten the radial length and unblock the passageway.
Patent AT-E228534-T1 (AT)
Inventor: BUCHARDT OLE
IPC: C12N15/09
Filed: 1994-06-28
Granted: 2002-12-15
Abstract: Peptide nucleic acids and analogues of peptide nucleic acids are used to form duplex, triplex, and other structures with nucleic acids and to modify nucleic acids. The peptide nucleic acids and analogues thereof also are used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids.
Patent AT-E255640-T1 (AT)
Inventor: DOUGLAS CAMERON M
IPC: G01N33/53
Filed: 1994-10-11
Granted: 2003-12-15
Abstract: PCT No. PCT/US94/11498 Sec. 371 Date Aug. 1, 1996 Sec. 102(e) Date Aug. 1, 1996 PCT Filed Oct. 11, 1994 PCT Pub. No. WO95/10625 PCT Pub. Date Apr. 20, 1995DNA molecules encoding proteins involved in biosynthesis of 1,3-beta-D glucan are identified, cloned, expressed and used in in vitro assays to screen for antifungal compounds, including compounds that affect cell wall biosynthesis. The invention includes but is not limited to the purified DNA molecules, assays employing the DNA molecules, proteins encoded by the DNA molecules, cells expressing the DNA molecules and altered forms of the molecules.
Patent AT-E182392-T1 (AT)
Inventor: BRINKMANN MANFRED
IPC: F16B12/26
Filed: 1995-02-23
Granted: 1999-08-15
Abstract: The fixture comprises a first and second parts (3,4) fixable to corresponding first and second furniture parts. At least one rigid securing cam is arranged on the first fixture part. The cam, in the locked state, is engaged by a securing nose formation on a spring-elastic securing tongue (7) of the second fixture part. The securing tongue is movable from its locking state into a release position in which it is fixable with positive engagement. The securing tongue in the release position is fixed by an arresting cam (10) formed on the second fixture part. <IMAGE>
Patent AT-E190109-T1 (AT)
Inventor: BIELA GEORG
IPC: E05B15/00
Filed: 1995-09-18
Granted: 2000-03-15
Abstract: The bolt (3), as the result of a force release by the force accumulator (6), moves out into a frame-side closure plate. A force transmission, which can be coupled in and out, is provided between the force accumulator and the bolt, whereby the coupling (7) with the bolt moved outwards is uncoupled. The coupling, the force transmission device (10) and the force accumulator are arranged in the door. A second force accumulator (15) with a second force transmission component (48) as the result of force release draws back the bolt. The coupling is arranged between a drive rod driving the bolt and an operating rod (8) of the force accumulator.
Patent AT-E178031-T1 (AT)
Inventor: SCHEI ANDERS
IPC: C01B33/00
Filed: 1995-08-31
Granted: 1999-04-15
Abstract: The present invention relates to a process for removing impurities from molten silicon by treatment of molten silicon (4) contained in a vessel (2) with a slag (5) having the capability of removing the impurities, particularly boron, from molten silicon. The slag (5) is continuously or substantially continuously added to the molten silicon (4) and then continuously or substantially continuously inactivated or removed from the silicon melt (4) as soon as equilibrium between the slag (6) and molten silicon (4) is reached with respect to the impurity elements or element to be removed. <MATH>
Patent AT-E172996-T1 (AT)
Inventor: PITTELOUD RITA DR
IPC: C08L23/02
Filed: 1995-05-19
Granted: 1998-11-15
Abstract: Oligomeric cpds. of formula (I) are claimed, where L is -O-R2-O- or -NR4-X-R3-O-; R1 is a 1-25C alkyl, 2-25C alkyl with in-chain O, S or >NR5, 2-24C alkenyl, 5-15C cycloalk(en)yl (opt. substd. with 1-4C alkyl), 7-9C phenylalkyl (opt. ring-substd. with 1-4C alkyl) tetrahydroabietyl, etc.; R2 is e.g. -R3-N(Y)-R3-;Y is a gp. of formula (iii); R3 is a 1-18C alkylene, 2-18C alkylene with in-chain O, S or >NR5, 4-8C alkenylene or phenylethylene; R4 is a 1-8C alkyl or gp. of formula (iii); R5 is H or 1-8C alkyl; R10 is H, 1-8C alkyl, O, OH, NO, CH2CN, 1-18C alkoxy, 5-12C cycloalkoxy, 3-6C alkenyl, or alkynyl, 1-8C acyl or 7-9C phenylalkyl (opt. ring substd. with 1-4C alkyl); m = 0 or 1; and n = 2-25. Also claimed are (a) a process for the prodn. of (I) by reacting cpds. of formula R1-(O)m-PCl2, (XXII) with cpds. of formula H-L-H (XXIII); (b) oligomeric cpds. obtd. by the process; (c) compsns. (A) contg. (1) organic material which is subject to oxidative, thermal or light induced degradation, and (2) cpd(s). (I) or the oligomeric prod(s).; and (d) a process for stabilising organic materials, against degradation as above, by mixing or coating the material with (I).
Patent AT-E172402-T1 (AT)
Inventor: ROCKSTEDT SIEGWARD
IPC: B29B7/48
Filed: 1994-11-11
Granted: 1998-11-15
Abstract: The invention relates to a multiscrew, continuous mixing machine for plasticizable compounds with two screws, which rotate in a housing and which penetrate the cylindrical part of the housing that envelops the screw concerned and exhibit feed and metering sections and inbetween at least one homogenizing section and a mixing section, whereby the feed and metering sections are formed by intermeshing conveying screws, which rotate in the same direction and are arranged in the mixing elements, which are opposite the homogenizing and mixing sections and whose edges travel past each other with little clearance while rotating, whereby to form a chamber extending above the mixing elements, the edges maintain a distance from the part of the housing enveloping said edges that is significantly greater than the clearance. The mixing elements comprise process screw elements, whose lengths are in essence identical and which exhibit such a pitch that within the chamber the one process screw element feeds forward and the other process screw element feeds backward.
Patent AT-E157168-T1 (AT)
Inventor: HOFF LOUIS B
IPC: G01N21/64
Filed: 1995-01-31
Granted: 1997-09-15
Abstract: This invention relates to an improved real-time scanning fluorescence electrophoresis apparatus for the electrophoretic analysis of fluorescently-labeled polynucleotide fragments. The apparatus is characterized by having an electrophoresis chamber containing an electrophoretic separation medium capable of accommodating multiple electrophoresis lanes arranged in a planar array, a fluorescence detector mounted on a translatable stage, a light source for exciting fluorescent molecules, and a computer for collecting data consisting of time, location, fluorescence wavelength and fluorescent intensity information. The improvements herein disclosed include, (i) using a spectral-array detector for detecting the emission light from the fluorescently-labeled polynucleotide fragments including the simultaneous detection of multiple fluorescent labels, and, (ii) a temperature control means to control the temperature of the electrophoretic separation medium during electrophoresis.
Patent AT-E197359-T1 (AT)
Inventor: LEALMAN IAN FRANCIS
IPC: G02B6/30
Filed: 1995-02-24
Granted: 2000-11-15
Abstract: A semiconductor optical device, for example a laser, has a composite optical waveguide comprising a tapered, MQW active waveguide (1), in optical contact with a substantially planar, passive waveguide (2). The fundamental optical mode supported by the composite waveguide varies along the length of the composite waveguide so that, in a laser, the laser mode is enlarged and is a better match to single mode optical fibre. A method for making such semiconductor optical devices is also disclosed.
Patent AT-E163330-T1 (AT)
Inventor: BRENNESHOLTZ MATTHEW
IPC: H01J29/07
Filed: 1995-04-18
Granted: 1998-03-15
Abstract: A one-dimensional tension mask-frame assembly for a color cathode ray tube includes a rectangular frame whose top and bottom members each have inwardly flexed upstanding portions with a spring constant, and a rectangular mask secured to the frame along the free edges of the upstanding frame portions, the frame portions maintaining the mask in a state of tension during thermal expansion of the mask. The assembly is useful in color display applications such as T.V.
Patent AT-E196171-T1 (AT)
Inventor: FOSTER JOHN
IPC: F01D5/28
Filed: 1995-07-24
Granted: 2000-09-15
Abstract: PCT No. PCT/GB95/01746 Sec. 371 Date Jul. 16, 1996 Sec. 102(e) Date Jul. 16, 1996 PCT Filed Jul. 24, 1995 PCT Pub. No. WO96/03536 PCT Pub. Date Feb. 8, 1996A method of producing a coating on a substrate by electrolytically co-depositing a metal matrix M1 and particles of CrAlM2, where M1 is Ni, Co or Fe or two or all of these elements and M2 is Y, Si, Ti, Hf, Ga, Nb, Mn, Pt, a rare earth element or two or more of these elements. The co-deposition is carried out at a current density of less than 5mA per square centimeter. Preferably, the co-deposition forms a layer less than 50 microns thick, and occurs at a bath loading of less than 40 grams per liter of the particles. In a preferred embodiment, the particle size distribution in the plating bath is 25 percent between 15 and 12 microns, 45 percent between 12 and 10 microns and 30 percent less than 10 microns. The method is particularly useful for coating a gas turbine part.
Patent AT-E395922-T1 (AT)
Inventor: KUCERA LOUIS S
IPC: A61K31/685
Filed: 1995-08-07
Granted: 2008-06-15
Abstract: A method of treating viral infections, and in particular HIV-1, hepatitis B virus, and herpesviruses, is disclosed. The method comprising administering to a subject in need of such treatment an infection-combating amount of a phospholipids or phospholipids derivative.
Patent AT-E232732-T1 (AT)
Inventor: SUHADOLNIK ROBERT F
IPC: C07H21/02
Filed: 1995-08-22
Granted: 2003-03-15
Abstract: Optically active antiviral compounds having the formula   <IMAGE>   <IMAGE>   wherein m is 0, 1, 2, or 3; n and q are selected from the group of 0 and 1, provided that n and q may not both be zero; and R, R1, and R2 are independently of each other selected from the group consisting of oxygen and sulfur, provided that all R, R1 and R2, may not be oxygen, and further provided that all R, R1, and R2 may not be sulfur. The compounds possess increased antiviral activity and/or metabolic stability.
Patent AT-E210984-T1 (AT)
Inventor: OTOMO EIICHI
IPC: C07D295/20
Filed: 1996-01-11
Granted: 2002-01-15
Abstract: The present invention provides an agent for treating mental disorders resulting from cerebrovascular disorder. Olanzapine, a compound which can block both serotonin-2 and dopamine-2 receptors is useful as a therapeutic agent therefor.
Patent AT-E168333-T1 (AT)
Inventor: SCHMIDT ERNST
IPC: B60P7/06
Filed: 1996-04-10
Granted: 1998-08-15
Abstract: The device consists of a mounting (7) fitted to a side wall (3,4,6) of the loading platform (2), a retainer element (8) and a unit (9) connecting the two, to move the retainer relative to the mounting, in a direction at right angles to the wall. A locking mechanism (31) locks the retainer in that position. The connection unit has a scissor-type mechanism. The retainer consists of a plate at right angles to the loading platform, and it has an actuating lever (30). It has a further pivoted retainer element and fixing straps on the side away from the connection unit.
Patent AT-E234508-T1 (AT)
Inventor: ECKSTEIN ELKE
IPC: C23F4/00
Filed: 1996-04-11
Granted: 2003-03-15
Abstract: A back end of the line dry etch method is disclosed. Etching of a mask oxide and temporary (sacrificial) silicon mandrel occurs following the formation of gate stacks and tungsten studs. The mask oxide is etched selectively to tungsten and silicon through the use of a polymerizing oxide etch. The silicon is etched selectively to both silicon nitride, silicon oxide, and tungsten. The process removes the silicon mandrel and associated silicon residual stringers by removing backside helium cooling, while using HBr as the single species etchant, and by adjusting the duration, the pressure, and the electrode gaps during the silicon etch process. The silicon may be undoped polysilicon, doped polysilicon, or single crystal silicon. <IMAGE>
Patent AT-E213545-T1 (AT)
Inventor: HARTWIG HAGEN DIPL-ING
IPC: G01R15/18
Filed: 1996-05-03
Granted: 2002-03-15
Abstract: The current converter consists of a magnetic field sensor which receives the value of a primary current (il), followed by a control stage which evaluates the measured primary current. The control stage produces a compensation current which is then amplified by an amplifier stage. The compensation current flows through a resistor through which a voltage proportional to the primary current drops. This forms a counter clock end stage along with an inverting amplifier and a differential amplifier. A latch-up supervisor monitors the symmetry, the positive or negative supply voltage, and the controller sum point to determine irregular values.
Patent AT-E170956-T1 (AT)
Inventor: BERND UTHE DIPL-ING
IPC: E04F13/08
Filed: 1996-05-14
Granted: 1998-09-15
Abstract: The equipment has retaining (1) and fastening (5) elements to fix an installation component (3), and can accommodate dimensional inaccuracies on a supporting structure (2), especially on a house shell. A slide (4) is located between the fastening element and the component, and has holes (6) arranged in a predetermined grid pattern. The spacing between the holes is smaller than the base tolerances (X,Y) in the position of the retaining element in the structure. The slide has resting surfaces (4a,4b) which run across the fastening element, and at least one flat supporting surface (4c), which is parallel to the axis of the element, and which can rest on an associated surface (3c) on the component in order to support the element positively. The component has an opening (7) whose extent (a') in the adjusting region (a) of the grid corresponds to at least the distance between two holes plus the diameter of the retaining or fastening element which projects through it.
Patent AT-E183065-T1 (AT)
Inventor: RIEK SIEGFRIED DR MED
IPC: A61B17/00
Filed: 1996-11-28
Granted: 1999-08-15
Abstract: A medical needle for endoscopic surgery has an external cannula tube in which a protective element is mounted so that it can be shifted axially against a spring. The distal, front protective surface of the protective element in a forward position projects beyond the sharp tip of the cannula tube and in a rear position is behind this tip. The protective surface of the protective element is transparent and can be observed through an optical system installed in the protective element.
Patent AT-E204231-T1 (AT)
Inventor: WIDMAN MICHAEL
IPC: B29C33/60
Filed: 1996-09-27
Granted: 2001-09-15
Abstract: Hydrophilic contact lens molds are transiently modified to provide a water dynamic contact angle equal to or less than 100 DEG  by treatment with a wetting agent which may be water or a surfactant composition which provides a mold surface having a water wetting force of at least 70 mg to afford a reduction in lens hole defects in hydrophilic contact lens manufacture.
Patent AT-E293689-T1 (AT)
Inventor: WELLS TIMOTHY NIGEL CARL
IPC: G01N33/53
Filed: 1996-01-24
Granted: 2005-05-15
Abstract: A chemokine receptor binds to MCP-1, MIP-1alpha and/or RANTES. It can be used in screening for agents which act as antagonists to MCP-1, MIP-1alpha and/or RANTES. Such agents may be useful in treating various disorders, including allergies, atheromas and diseases mediated by viruses. They may also be useful in preventing graft rejection and in protecting stem cells from potentially damaging effects of chemotherapy.
Patent AT-E213228-T1 (AT)
Inventor: HENSHILWOOD JAMES
IPC: C07D491/10
Filed: 1996-04-02
Granted: 2002-02-15
Abstract: The subject invention concerns a process for the preparation of a compound of formula (2), which comprises phenolic oxidation of a compound of formula (1)wherein X1 and X2 are independently selected from H or a protecting group for the phenolic function, e.g. acyl or trialkylsilyl; groups A1, A2, B1, B2 and Y are selected so as to render the nitrogen atom non-basic; Z is a blocking group, e.g. Br or t-butyl; and R is H, alkyl, aryl, or arylalkyl, and wherein the process is carried out in a two-phase liquid system comprising an aqueous base and an organic solvent having a dielectric constant below 4.8.
Patent AT-E190239-T1 (AT)
Inventor: HINKE THOMAS V
IPC: B01D53/77
Filed: 1996-05-29
Granted: 2000-03-15
Abstract: A system and method for the reduction of NOx in a flue gas are disclosed. A P4 in water liquid/liquid emulsion is injected into a flue gas having a temperature of about 180 DEG  C. to about 280 DEG  C. to induce phosphorus-accelerated oxidation of the NO in the flue gas. NO2 and phosphorus oxides are subsequently removed from the flue gas stream at a location sufficiently downstream of the injection site that the oxidation of NO in the flue gas is substantially complete prior to the removal of NO2. This significantly improves the NOx recovery rate of the present system and method over those of the prior art. The system can be retrofitted to the waste gas stream of any stationary combustion source regardless of the fuel burned. The system is advantageously used in connection with a wet scrubber for the removal of NO2 and other water soluble flue gas components. Injection of the emulsion results in the creation of ozone by means of the controlled oxidation of white phosphorus. The ozone reacts with nitrogen oxide (NO), which generally accounts for 90% of flue gas NOx, to produce nitrogen dioxide (NO2). The reaction products (NO2 and the P4O10,) can be removed from the flue gas together with SO2 and particulates in the wet scrubber wherein they are efficiently transferred from the gaseous phase to the buffered scrubbing liquid. In the scrubber, the temperature gradient is preferably set through the dew point, so that it recovers both latent as well as sensible heat energy from the flue gas which energy can be sold to commercial or residential consumers to recover at least a part of the capital costs (purchase and operation) associated with the system.
Patent AT-E194266-T1 (AT)
Inventor: HONKALA MARKKU
IPC: A41D31/00
Filed: 1996-06-06
Granted: 2000-07-15
Abstract: PCT No. PCT/FI96/00336 Sec. 371 Date Feb. 5, 1997 Sec. 102(e) Date Feb. 5, 1997 PCT Filed Jun. 6, 1996 PCT Pub. No. WO96/39881 PCT Pub. Date Dec. 19, 1996An impact-resistant garment comprises closed rings (2) joined together to form a layer (1) protecting against impacts inside the garment. Elongate filling elements (3) of limited flexibility are threaded through the rings (2) to prevent the penetration of spike-shaped objects through the rings (2).
Patent AT-E290350-T1 (AT)
Inventor: NAUGHTON GAIL K
IPC: A61L27/00
Filed: 1996-06-06
Granted: 2005-03-15
Abstract: The present invention is directed to methods for producing naturally secreted human extracellular matrix material and compositions containing the extracellular matrix material. The method includes culturing extracellular matrix-secreting human stromal cells on a biocompatible three-dimensional framework in vitro. After secretion of the extracellular matrix onto the framework, the stromal cells are killed and the cells and cellular contents are removed from the framework. The extracellular matrix material deposited on the framework is collected and further processed to obtain a physiologically acceptable compositions. The compositions of the present invention are useful for the repair of soft tissue and skin defects, including wrinkles and scars.